(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).Visual inspection was performed on the returned device.The separation was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history of the reported lot revealed no other incidents.It should be noted that the rx acculink instruction for use states: the rx acculink carotid stent system, is indicated for the treatment of patients who require carotid revascularization.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
|
It was reported that the procedure was to treat a lesion in the right superficial femoral artery.The 6-8x40mm acculink stent was deployed successfully at the lesion; however, during removal of the stent delivery system, it was noted that the distal shaft separated into two pieces.The separated portion of the device was simply removed.The patient remained stable.There was no resistance noted during advancement or withdrawal of the device and no force applied.There was no reported adverse patient effect or a clinically significant delay in the procedure.No additional information was provided.
|